相似文献
1
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.
Chin J Cancer Res. 2017 Aug;29(4):281-293. doi: 10.21147/j.issn.1000-9604.2017.04.01.
2
Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition).
Eur J Nucl Med Mol Imaging. 2025 Mar 25. doi: 10.1007/s00259-025-07222-1.
3
[Expert consensus on whole-course management of prostate cancer (2025 edition)].
Zhonghua Zhong Liu Za Zhi. 2025 Jul 23;47(7):617-634. doi: 10.3760/cma.j.cn112152-20250212-00053.
4
[Expert consensus on the treatment of advanced lung cancer in elderly patients (2025 edition)].
Zhonghua Zhong Liu Za Zhi. 2025 Jul 23;47(7):575-598. doi: 10.3760/cma.j.cn112152-20250326-00128.
5
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.
Health Technol Assess. 2005 Jul;9(25):1-142. doi: 10.3310/hta9250.
6
[Multidisciplinary expert consensus on ultrasound-guided thermal ablation for non-lactating mastitis (2025 edition)].
Zhonghua Nei Ke Za Zhi. 2025 Jul 1;64(7):625-634. doi: 10.3760/cma.j.cn112138-20241206-00804.
7
Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).
Eur J Surg Oncol. 2009 Aug;35(8):787-92. doi: 10.1016/j.ejso.2009.01.003. Epub 2009 Jan 29.
8
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
9
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000. doi: 10.1016/j.joca.2007.06.014. Epub 2007 Aug 27.
10
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG).
Dig Liver Dis. 2025 May 30. doi: 10.1016/j.dld.2025.04.020.
引用本文的文献
1
A machine learning model integrating clinical-radiomics-deep learning features accurately predicts postoperative recurrence and metastasis of primary gastrointestinal stromal tumors.
Insights Imaging. 2025 Jun 26;16(1):135. doi: 10.1186/s13244-025-02011-8.
2
Endoscopic resection for gastric subepithelial tumours: a retrospective cohort study.
Ann Med. 2025 Dec;57(1):2514788. doi: 10.1080/07853890.2025.2514788. Epub 2025 Jun 14.
3
Study of genetic polymorphisms and steady-state trough concentrations of imatinib and its active metabolite in predicting efficacy in gastrointestinal stromal tumors.
Front Pharmacol. 2025 May 19;16:1604619. doi: 10.3389/fphar.2025.1604619. eCollection 2025.
4
RNA profiling and immunohistochemistry analyses of circRNAs in imatinib-resistant gastrointestinal stromal tumors.
J Transl Med. 2025 May 30;23(1):601. doi: 10.1186/s12967-025-06598-w.
5
Unraveling the site-specific features in small intestinal stromal tumors: a retrospective study.
BMC Gastroenterol. 2025 May 7;25(1):337. doi: 10.1186/s12876-025-03945-5.
6
The feasibility of endoscopic resection for esophageal gastrointestinal stromal tumor.
Surg Endosc. 2025 Jun;39(6):3718-3726. doi: 10.1007/s00464-025-11763-9. Epub 2025 May 2.
7
The first case of primary extragastrointestinal stromal tumor of the kidney: a case description.
Quant Imaging Med Surg. 2025 Apr 1;15(4):3723-3728. doi: 10.21037/qims-24-1678. Epub 2025 Mar 28.
8
Management of subepithelial esophageal tumors.
Innov Surg Sci. 2024 Aug 20;10(1):21-30. doi: 10.1515/iss-2023-0011. eCollection 2025 Mar.
9
Inflammatory biomarker correlations and prognosis in high-risk gastrointestinal stromal tumor patients: a multicenter retrospective analysis.
BMC Gastroenterol. 2025 Feb 26;25(1):119. doi: 10.1186/s12876-025-03710-8.
10
Efficacy analysis of modified double band ligation-assisted endoscopic submucosal resection and endoscopic mucosal dissection in the treatment of gastric gastrointestinal stromal tumors (≤ 1.5 cm).
Surg Endosc. 2025 Apr;39(4):2471-2480. doi: 10.1007/s00464-025-11598-4. Epub 2025 Feb 24.
本文引用的文献
1
Can laparoscopic surgery be applied in gastric gastrointestinal stromal tumors located in unfavorable sites?: A study based on the NCCN guidelines.
Medicine (Baltimore). 2017 Apr;96(14):e6535. doi: 10.1097/MD.0000000000006535.
2
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Hum Pathol. 2017 Apr;62:206-214. doi: 10.1016/j.humpath.2017.01.005. Epub 2017 Feb 1.
3
Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.
J Cancer Res Clin Oncol. 2017 Apr;143(4):727-734. doi: 10.1007/s00432-016-2334-x. Epub 2017 Jan 12.
4
The cut-off value of tumor size and appropriate timing of follow-up for management of minimal EUS-suspected gastric gastrointestinal stromal tumors.
BMC Gastroenterol. 2017 Jan 11;17(1):8. doi: 10.1186/s12876-016-0567-4.
5
A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment.
Medicine (Baltimore). 2016 Dec;95(49):e5488. doi: 10.1097/MD.0000000000005488.
6
[A Chinese multi-center study on the significance of monitoring imatinib plasma concentration in patients with gastrointestinal stromal tumor before and after administration].
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Nov 25;19(11):1271-1276.
7
[Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study].
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Nov 25;19(11):1258-1264.
8
The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation.
PLoS One. 2016 Dec 2;11(12):e0167720. doi: 10.1371/journal.pone.0167720. eCollection 2016.
9
Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
Virchows Arch. 2017 Jan;470(1):29-36. doi: 10.1007/s00428-016-2044-4. Epub 2016 Nov 18.
10
"Wild type" GIST: Clinicopathological features and clinical practice.
Pathol Int. 2016 Aug;66(8):431-7. doi: 10.1111/pin.12431. Epub 2016 Jul 18.
Zotero 插件